Pure Mucinous Breast Carcinoma In Young Female: A Rare Entity With Good Prognosis Among Infiltrating Breast Carcinoma S

doi:10.5281/zenodo.7690376

International Journal of Medical and Pharmaceutical Research

2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7690376

Case Report

Pure Mucinous Breast Carcinoma In Young Female: A Rare Entity With Good Prognosis Among Infiltrating Breast Carcinoma S

Dr Parth R. Goswami & Dr Alpeshpuri Goswami

DOI : 10.5281/zenodo.7690376

Published

March 2, 2023

Abstract

Mucinous Breast carcinoma is rare malignant breast neoplasm and it constitute only 1-2 % of all invasive breast cancers. Tumor called as Pure mucinous breast cancer when mucinous component is 90% of the tumor. We present a case report of 36-year-old female patient with approximately 3x2 cm size mass on left breast. Lumpectomy specimen of breast with wide local excision received. This tumor was classified as grade 1 (well differentiated) according to modified scarf bloom Richardson grading system. Mucinous breast carcinoma commonly observed in old aged female. This type tumor of tumor usually shows immune histochemistry positivity for ER, PR and HER2 negative which indicate towards good prognosis. Pure mucinous breast carcinoma is very rare entity among all infiltrating breast carcinoma. It is very rarely observed in young age female patient & prognosis is excellent if diagnosed correctly. Therefore, we present this rare case report in this journal.

Recommended Articles

Volume-4, Issue-2

Downloads

Download PDF pdf

Download XML

Citations

2567 Views

416 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.